You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 22, 2024

CLINICAL TRIALS PROFILE FOR ETHYOL

✉ Email this page to a colleague

« Back to Dashboard

All Clinical Trials for ETHYOL

Subscribe to access the full database, or Sign Up
Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT00003048 ↗	Amifostine in Treating Patients With Myelodysplastic Syndrome	Completed	National Cancer Institute (NCI)	Phase 2	1997-06-05	RATIONALE: Amifostine may improve blood counts in patients with myelodysplastic syndrome. PURPOSE: Phase II trial to study the effectiveness of amifostine in treating patients with myelodysplastic syndrome.
NCT00003048 ↗	Amifostine in Treating Patients With Myelodysplastic Syndrome	Completed	M.D. Anderson Cancer Center	Phase 2	1997-06-05	RATIONALE: Amifostine may improve blood counts in patients with myelodysplastic syndrome. PURPOSE: Phase II trial to study the effectiveness of amifostine in treating patients with myelodysplastic syndrome.
NCT00003072 ↗	Combination Chemotherapy in Treating Patients With Metastatic Ovarian Cancer or Non-small Cell Lung Cancer	Completed	University of California, San Francisco	Phase 2	1997-05-01	RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug and giving the drugs in different combinations may kill more tumor cells. PURPOSE: Randomized phase II double-blinded trial to study the effectiveness of paclitaxel and carboplatin given with either amifostine or placebo in patients with metastatic stage III or stage IV ovarian cancer or metastatic stage III or stage IV non-small cell lung cancer.
NCT00003123 ↗	Amifostine in Treating Patients With Advanced Myelodysplastic Syndrome	Unknown status	Providence Hospital	Phase 2	1997-08-01	RATIONALE: Amifostine may be effective in helping blood counts return to normal in treating patients with myelodysplastic syndrome. PURPOSE: Phase II trial to study the effectiveness of amifostine in treating patients with advanced myelodysplastic syndrome.
NCT00003127 ↗	S9720 Combination Chemotherapy in Treating Patients With Metastatic, Recurrent, or Refractory Endometrial Cancer	Completed	National Cancer Institute (NCI)	Phase 2	1998-02-01	RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells. PURPOSE: Phase II trial to study the effectiveness of combination chemotherapy in treating patients with metastatic, recurrent, or refractory endometrial cancer.
NCT00003127 ↗	S9720 Combination Chemotherapy in Treating Patients With Metastatic, Recurrent, or Refractory Endometrial Cancer	Completed	Southwest Oncology Group	Phase 2	1998-02-01	RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells. PURPOSE: Phase II trial to study the effectiveness of combination chemotherapy in treating patients with metastatic, recurrent, or refractory endometrial cancer.
>Trial ID	>Title	>Status	>Sponsor	>Phase	>Start Date	>Summary

Clinical Trial Conditions for ETHYOL

Condition Name

Chart
Table

Condition Name for ETHYOL
Intervention	Trials
Head and Neck Cancer	8
Lung Cancer	5
Myelodysplastic Syndromes	5
Leukemia	4
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Condition MeSH

Chart
Table

Condition MeSH for ETHYOL
Intervention	Trials
Head and Neck Neoplasms	8
Syndrome	5
Preleukemia	5
Myelodysplastic Syndromes	5
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Locations for ETHYOL

Trials by Country

Map
Table

Trials by Country for ETHYOL
Location	Trials
United States	125
Canada	6
France	1
Israel	1
Australia	1
This preview shows a limited data set Subscribe for full access, or try a Trial

Trials by US State

Map
Table

Trials by US State for ETHYOL
Location	Trials
California	10
Ohio	6
New York	6
Illinois	6
Michigan	5
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Progress for ETHYOL

Clinical Trial Phase

Chart
Table

Clinical Trial Phase for ETHYOL
Clinical Trial Phase	Trials
Phase 4	2
Phase 3	4
Phase 2	15
[disabled in preview]	11
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Status

Chart
Table

Clinical Trial Status for ETHYOL
Clinical Trial Phase	Trials
Completed	22
Terminated	5
Unknown status	2
[disabled in preview]	3
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Sponsors for ETHYOL

Sponsor Name

Chart
Table

Sponsor Name for ETHYOL
Sponsor	Trials
National Cancer Institute (NCI)	14
MedImmune LLC	6
M.D. Anderson Cancer Center	3
[disabled in preview]	6
This preview shows a limited data set Subscribe for full access, or try a Trial

Sponsor Type

Chart
Table

Sponsor Type for ETHYOL
Sponsor	Trials
Other	30
NIH	14
Industry	10
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.